Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, Bionomics to Co-Develop Molecular Diagnostic for Epilepsy

NEW YORK, Oct. 1 - Nanogen and Bionomics today said they will work together to develop what they believe will be the world's first molecular-diagnostic test for epilepsy.


Under the terms of the collaboration, the partners will use Nanogen's NanoChip technology together with Bionomics' ionX discovery platform.


Though no financial details were disclosed, the companies agreed that Nanogen would hold exclusive license to any diagnostic-related IP that comes out of the collaboration. In return, Bionomics will be handed funding for research, as well as undisclosed payments for development and commercialization milestones.


Click here for more information.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.